News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,452 Results
Type
Article (39765)
Company Profile (271)
Press Release (655416)
Section
Business (204951)
Career Advice (2018)
Deals (35516)
Drug Delivery (95)
Drug Development (81139)
Employer Resources (169)
FDA (16167)
Job Trends (14884)
News (346159)
Policy (32589)
Tag
Academia (2554)
Alliances (49661)
Alzheimer's disease (1320)
Approvals (16150)
Artificial intelligence (199)
Bankruptcy (359)
Best Places to Work (11659)
Biotechnology (190)
Breast cancer (226)
Cancer (1714)
Cardiovascular disease (128)
Career advice (1681)
CAR-T (122)
Cell therapy (355)
Clinical research (65371)
Collaboration (665)
Compensation (370)
COVID-19 (2580)
C-suite (161)
Data (1630)
Diabetes (212)
Diagnostics (6309)
Earnings (85565)
Employer resources (146)
Events (111370)
Executive appointments (567)
FDA (17070)
Funding (606)
Gene therapy (245)
GLP-1 (652)
Government (4372)
Healthcare (18789)
Infectious disease (2692)
Inflammatory bowel disease (124)
Interviews (310)
IPO (16493)
Job creations (3662)
Job search strategy (1432)
Layoffs (443)
Legal (7920)
Lung cancer (255)
Manufacturing (236)
Medical device (13273)
Medtech (13278)
Mergers & acquisitions (19396)
Metabolic disorders (550)
Neuroscience (1723)
NextGen: Class of 2025 (6545)
Non-profit (4486)
Northern California (2094)
Obesity (306)
Opinion (197)
Patents (162)
People (57155)
Phase I (20375)
Phase II (28809)
Phase III (21428)
Pipeline (711)
Postmarket research (2563)
Preclinical (8607)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5944)
Regulatory (21988)
Research institute (2318)
Resumes & cover letters (350)
Southern California (1799)
Startups (3620)
United States (18491)
Vaccines (613)
Weight loss (209)
Date
Last 7 days (595)
Last 30 days (2470)
Last 365 days (34495)
2025 (4441)
2024 (35331)
2023 (40179)
2022 (51291)
2021 (55837)
2020 (54172)
2019 (46642)
2018 (35124)
2017 (32225)
2016 (31630)
2015 (37709)
2014 (31456)
2013 (26503)
2012 (28770)
2011 (29430)
2010 (27528)
Location
Africa (719)
Arizona (211)
Asia (37720)
Australia (6184)
California (4779)
Canada (1716)
China (393)
Colorado (218)
Connecticut (230)
Europe (80904)
Florida (688)
Georgia (165)
Illinois (458)
Indiana (260)
Maryland (740)
Massachusetts (3614)
Michigan (198)
Minnesota (334)
New Jersey (1350)
New York (1360)
North Carolina (834)
Northern California (2094)
Ohio (175)
Pennsylvania (1100)
South America (1096)
Southern California (1799)
Texas (705)
Utah (143)
Washington State (468)
695,452 Results for "igm biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
January 9, 2025
·
4 min read
Business
IGM Biosciences Announces Refocusing of Sanofi Collaboration
IGM Biosciences, Inc. today announced that the Company’s exclusive worldwide collaboration agreement with Sanofi to create and develop IgM agonist antibodies will now focus exclusively on immunology/inflammation targets.
April 17, 2024
·
4 min read
Biotech Bay
IGM Biosciences to Present at the 2024 Jefferies Healthcare Conference
IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 5, 2024, at 2:30 p.m. EDT in New York.
May 29, 2024
·
1 min read
Biotech Bay
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
IGM Biosciences, Inc. announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, at 2:35 p.m. EDT.
May 7, 2024
·
1 min read
Business
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences, Inc., a clinical-stage biotechnology company creating and developing engineered IgM antibodies, announced its financial results for the fiscal quarter ended March 31, 2024 and provided an update on recent developments.
May 8, 2024
·
9 min read
Biotech Bay
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
IGM Biosciences, Inc., a clinical-stage biotechnology company creating and developing engineered IgM antibodies, announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Wednesday, April 17, 2024, at 12:00 p.m. EDT.
April 10, 2024
·
1 min read
Press Releases
IGM Biosciences to Present at Three Upcoming Investor Conferences in November 2024
November 5, 2024
·
1 min read
Press Releases
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
November 8, 2024
·
9 min read
Business
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced its financial results for the fourth quarter and full year ended December 31, 2023 and provided an update on recent developments.
March 7, 2024
·
9 min read
1 of 69,546
Next
